跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
APO-RISPERIDONE 1MG TABLET - HSA Drug Approval Details
Approvals
/
HSA
/
APO-RISPERIDONE 1MG TABLET
Approved
THERAPEUTIC
APO-RISPERIDONE 1MG TABLET
APOTEX INC. (CANADA)
🇸🇬 Health Sciences Authority
Approval Date
Dec 1, 2008
Approval ID
37aade0d29cac136
Company
APOTEX INC. (CANADA)
Type
Therapeutic
Approval Details
Approval Id
37aade0d29cac136
Drug Name
APO-RISPERIDONE 1MG TABLET
Product Name
APO-RISPERIDONE 1MG TABLET
Approval Number
SIN13578P
Approval Date
2008-12-01
Registrant
PHARMAFORTE SINGAPORE PTE LTD
Licence Holder
PHARMAFORTE SINGAPORE PTE LTD
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
TABLET, FILM COATED
Route Of Administration
ORAL
Atc Code
N05AX08
Atc Item Name
risperidone
Pharma Manufacturer Name
PHARMAFORTE SINGAPORE PTE LTD
Active Ingredients
Risperidone
1mg
Risperidone
1mg
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Dec 1, 2008
Approval ID
37aade0d29cac136
Type
Therapeutic
Back to HSA Approvals